Zymeworks Inc (NYSE:ZYME)
| 6.88 Delayed Data As of May 27 |  +0.51 / +8.01%Today’s Change | 4.56 Today|||52-Week Range 39.41 | -58.02% Year-to-Date |
Latest ZYME News | Press Releases
No recent news for Zymeworks Inc.
Today’s Trading
| Previous close | 6.37 |
| Today’s open | 6.57 |
| Day’s range | 6.28 - 6.99 |
| Volume | 2,341,644 |
| Average volume (3 months) | 1,636,467 |
| Market cap | $345.8M |
Data as of 4:07pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -14.67% |
| Earnings growth (this year) | +16.86% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | -31.50% |
| P/E ratio | NM |
| Price/Sales | 31.67 |
| Price/Book | 1.12 |
Competitors
| ---- | ||
| --Cassiopea SpA | 0.00 | 0.00% |
| ---- | ||
| ESPREsperion Therapeutic... | +0.29 | +5.26% |
Data as of 3:59pm ET, 05/27/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.99 |
| Annual revenue (last year) | $26.7M |
| Annual profit (last year) | -$211.8M |
| Net profit margin | -794.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Vancouver, British Columbia |
Forecasts
